02/09/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

02/09/2024

Sep 2, 2024, 07:00 | Blog
The connection between a new class of weight loss drugs and cancer risk reduction - MSKCC
Memorial Sloan Kettering Cancer Center shared a post on X: "In this episode of Cancer Straight…
Sep 2, 2024, 06:54 | Societies
The beginning of Gold September - SIOP Europe
SIOP Europe shared on LinkedIn: "Today marks the beginning of Gold September – Childhood Cancer…
Sep 2, 2024, 06:48 | Societies
American Society of Clinical Oncology (ASCO)'s Medical Education Community of Practice TOWN HALL
Jonathan Lim, Medical Oncologist and Postdoctoral Clinical Fellow at The Francis Crick Institute, shared on LinkedIn:…
Sep 2, 2024, 04:06 | Insight
23rd Annual Hispanic Women of Distinction Charity Luncheon
Sylvester Comprehensive Cancer Center shared a post on LinkedIn: “Today marked the 23rd Annual Hispanic…
Sep 2, 2024, 03:56 | Insight
Francisco J. Esteva: The critical role of regular screenings in improving breast cancer outcomes
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared a…
Sep 2, 2024, 03:50 | Insight
National Cancer Society Malaysia is one of the proud recipients of the Home Away From Home grant
Childhood Cancer International (CCI) shared a post on LinkedIn: “The National Cancer Society Malaysia (NCSM)…
Sep 2, 2024, 03:41 | Insight
FDA Grants Zongertinib Breakthrough Therapy Designation in HER2-Mutant NSCLC
The FDA has recently granted Zongertinib, a HER2-specific tyrosine kinase inhibitor (TKI), Breakthrough Therapy Designation…
Sep 2, 2024, 03:14 | Insight
Othman Al-Sawaf: Surrogacy of endpoints in 1L CLL trials
Othman Al-Sawaf, Haematologist and Medical Oncologist at the University Hospital Cologne, Cologne, Germany, shared a…
All: 98 Posts: 91 - 100
Special Coverage